Clinical, hemodynamic, and neuroendocrine effects of chronic prazosin therapy for congestive heart failure.
暂无分享,去创建一个
[1] R. Alexander,et al. Regulation of the Postsynaptic α‐Adrenergic Receptor in Rat Mesenteric Artery: Effects of Chemical Sympathectomy and Epinephrine Treatment 1981 , 1981, Circulation research.
[2] E. Braunwald,et al. Increased plasma norepinephrine levels during prazosin therapy for severe congestive heart failure. , 1980, Annals of internal medicine.
[3] R. Alexander,et al. Characterization of Postsynaptic Alpha‐Adrenergic Receptors by [8H]‐Dihydroergocryptine Binding in Muscular Arteries from the Rat Mesentery , 1980, Hypertension.
[4] E. Braunwald,et al. Long-term therapy of heart failure with prazosin: a randomized double blind trial. , 1980, The American journal of cardiology.
[5] L. Johnson,et al. Improved exercise ejection fraction with long-term prazosin therapy in patients with heart failure. , 1980, The American journal of medicine.
[6] C. Conti,et al. Comparison of haemodynamic effects of oral prazosin, oral hydralazine, and intravenous nitroprusside in same patients with chronic heart failure. , 1979, British heart journal.
[7] L. Benet,et al. Attenuation of prazosin effect on cardiac output in chronic heart failure. , 1979, Annals of internal medicine.
[8] E. Sonnenblick,et al. Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure. , 1979, The American journal of cardiology.
[9] W. Pettinger,et al. Effects of Prazosin and Phentolamine on Arterial Pressure, Heart Rate, and Renin Activity: Evidence in the Conscious Rat for the Functional Significance of the Presynaptic α-Receptor , 1979, Journal of cardiovascular pharmacology.
[10] B. Brundage,et al. Paradox of improved exercise but not resting hemodynamics with short-term prazosin in chronic heart failure. , 1979, The American journal of cardiology.
[11] R. Gorlin,et al. Hemodynamic and Clinical Tachyphylaxisc to Prazosin-Mediated Afterload Reductionin Severe Chronic Congestive Heart Failure , 1979, Circulation.
[12] W. Aronow,et al. Effect of Prazosin vs Placebo on Chronic Left Ventricular Heart Failure , 1979, Circulation.
[13] J. Wikberg. Pharmacological classification of adrenergic α receptors in the guinea pig , 1978, Nature.
[14] R. Miller,et al. Efficacy of Ambulatory Systemic Vasodilator Therapy with Oral Prazosin in Chronic Refractory Heart Failure: Concomitant Relief of Pulmonary Congestion and Elevation of Pump Output Demonstrated by Improvements in Symptomatology, Exercise Tolerance, Hemodynamics and Echocardiography , 1977, Circulation.
[15] R. Miller,et al. Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin. , 1977, The New England journal of medicine.
[16] S. Z. Langer,et al. Presynaptic regulation of catecholamine release. , 1974, Biochemical pharmacology.
[17] Oxon Ma. Gerald Legh Malins McElligott. , 1972 .
[18] S. Taylor,et al. Phentolamine for vasodilator treatment of severe heart-failure. , 1971, Lancet.